TRA

Traphaco

38,800
+0.00%
Mkt Cap 3.2T
Data as of 2026-07-23 · Source: public Vietnamese market feeds

By Aveluro Research Team · Editorial policy

Traphaco (TRA) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 38,800 VND, little changed on the session, giving a market capitalization of 3.2 trillion VND.

On valuation, TRA trades at a price-to-earnings ratio of 11.1 and a price-to-book of 2.1. That is a discount to the Health Care sector average P/E of 22.2. Return on equity of 19.0% points to solid profitability relative to the company's equity base, above the sector average of 10.4%. Trailing earnings per share stand at 7,211 VND.

Aveluro tracks 6 news items mentioning TRA. The most recent catalyst was a dividend announcement event — "CTG, VCB Lead Cash Dividend Week: DBM Pays 35%, Banks Disburse Over VND 3,000B Each". Aveluro's composite model rates TRA 8.9/10 (Strong Buy), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMV and APC.

Latest price
38,800 VND · +0.00%
Dominant Sentiment
Neutral · 6 Articles Analyzed
Latest catalyst
dividend announcement
Data as of
2026-07-23

CTG, VCB Lead Cash Dividend Week: DBM Pays 35%, Banks Disburse Over VND 3,000B Each

Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.

8.9
Strong Buy
Sentiment
+1.00
Impact
0.40
Momentum
-1.00
Fundamentals
+1.00
Volume
1.00
P/E
11.1
P/B
2.1
ROE
19.0%
ROA
12.4%
EPS
7.2K
Articles Analyzed
6
Dominant Sentiment
Neutral
Neutral 3
Positive 3
Full Analysis dividend announcement Jul 18, 2026
CTG, VCB Lead Cash Dividend Week: DBM Pays 35%, Banks Disburse Over VND 3,000B Each

CTG and VCB will each disburse over VND 3,000 billion in cash dividends at 4.5% rate, with ex-date July 23 and 24 respectively. DBM pays the highest rate at 35%, benefiting major shareholder TRA. The payouts reflect strong cash positions but also signal limited reinvestment appetite.

4 +4.0 Positive
Read full analysis →
Full Analysis sector sentiment May 13, 2026
Foreign Ownership Dominates Vietnam's Top Pharma Stocks: DHG, IMP, DHT

Vietnam's top three pharma companies by market cap—DHG, IMP, and DHT—are now under foreign control or significant influence, with Taisho, Livzon, and ASKA as key shareholders. The sector is projected to double from $8-9 billion to $16 billion by 2032, driving M&A interest.

4 Neutral
Read full analysis →
Full Analysis m a announcement
Chinese Livzon Acquires 67.87% of Imexpharm (IMP) for VND 6,000B in Landmark Pharma M&A

IMP is now majority-owned by China's Livzon after a VND 6,000B deal for 67.87% of shares. The acquisition gives Livzon control of IMP's 12 EU-GMP production lines, a rare asset in Vietnam. The deal underscores a broader trend of foreign domination among top Vietnamese pharma firms, including DHG (Taisho), DMC (Abbott), and DHT (ASKA).

8 Neutral
Read full analysis →

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-07-23T11:46:06Z.